USA News

A new Alzheimer’s drug brings hope, controversy

A new Alzheimer’s drug brings hope, controversy – CBS News


Watch CBSN Live



The FDA’s recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer’s disease. But the approval process for Aduhelm has stirred controversy. Correspondent Susan Spencer talks with experts about the clinical benefits of this new class of drugs; and with early-onset Alzheimer’s patients, including a former neurologist who enrolled in an early trial of Aduhelm.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


File source

Tags
Show More

Related Articles

Back to top button
Close